Get started
GeoVax Labs, Inc.GeoVax Labs, Inc.GeoVax Labs, Inc.

GeoVax Labs, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GOVX chart


Full chart

GOVX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.84 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.1575 USD
Net income (FY)
‪−24.99 M‬ USD
Revenue (FY)
‪3.95 M‬ USD
Shares float
‪13.73 M‬
Beta (1Y)
4.43

Employees


Employees (FY)
17
Change (1Y)
0
Revenue / Employee (1Y)
‪232.62 K‬ USD
Net income / Employee (1Y)
‪−1.47 M‬ USD

About GeoVax Labs, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
David A. Dodd
Website
geovax.com
Headquarters
Smyrna
Founded
1988
FIGI
BBG000BGGJD8
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GOVX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as GOVX.

Frequently Asked Questions


The current price of GOVX is 0.9768 USD — it has decreased by −2.32% in the past 24 hours. Watch GeoVax Labs, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GeoVax Labs, Inc. stocks are traded under the ticker GOVX.
GOVX stock has risen by 7.33% compared to the previous week, the month change is a −28.18% fall, over the last year GeoVax Labs, Inc. has showed a −37.38% decrease.
We've gathered analysts' opinions on GeoVax Labs, Inc. future price: according to them, GOVX price has a max estimate of 18.00 USD and a min estimate of 8.00 USD. Watch GOVX chart and read a more detailed GeoVax Labs, Inc. stock forecast: see what analysts think of GeoVax Labs, Inc. and suggest that you do with its stocks.
GOVX reached its all-time high on Mar 14, 2000 with the price of 188,437,500,000.0000 USD, and its all-time low was 0.7300 USD and was reached on Apr 15, 2025. View more price dynamics on GOVX chart.
See other stocks reaching their highest and lowest prices.
GOVX stock is 23.05% volatile and has beta coefficient of 4.43. Track GeoVax Labs, Inc. stock price on the chart and check out the list of the most volatile stocks — is GeoVax Labs, Inc. there?
Today GeoVax Labs, Inc. has the market capitalization of ‪13.52 M‬, it has decreased by −18.68% over the last week.
Yes, you can track GeoVax Labs, Inc. financials in yearly and quarterly reports right on TradingView.
GeoVax Labs, Inc. is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
GOVX earnings for the last quarter are −0.88 USD per share, whereas the estimation was −0.80 USD resulting in a −9.12% surprise. The estimated earnings for the next quarter are −0.66 USD per share. See more details about GeoVax Labs, Inc. earnings.
GeoVax Labs, Inc. revenue for the last quarter amounts to ‪882.50 K‬ USD, despite the estimated figure of ‪2.97 M‬ USD. In the next quarter, revenue is expected to reach ‪1.67 M‬ USD.
GOVX net income for the last quarter is ‪−8.26 M‬ USD, while the quarter before that showed ‪−5.82 M‬ USD of net income which accounts for −42.08% change. Track more GeoVax Labs, Inc. financial stats to get the full picture.
No, GOVX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 17 employees. See our rating of the largest employees — is GeoVax Labs, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GeoVax Labs, Inc. EBITDA is ‪−25.05 M‬ USD, and current EBITDA margin is −633.42%. See more stats in GeoVax Labs, Inc. financial statements.
Like other stocks, GOVX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GeoVax Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GeoVax Labs, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GeoVax Labs, Inc. stock shows the sell signal. See more of GeoVax Labs, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.